Murine epidermal Langerhans cells do not express inducible nitric oxide synthase

被引:31
|
作者
Blank, C
Bogdan, C
Bauer, C
Erb, K
Moll, H
机构
[1] UNIV WURZBURG, RES CTR INFECT DIS, WURZBURG, GERMANY
[2] UNIV ERLANGEN NURNBERG, INST CLIN MICROBIOL & IMMUNOL, ERLANGEN, GERMANY
关键词
Langerhans cell; inducible nitric oxide synthase; Leishmania; nitric oxide;
D O I
10.1002/eji.1830260410
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In Leishmania-infected macrophages (M Phi), the formation of reactive nitrogen intermediates by the inducible isoform of nitric oxide synthase (iNOS) is critical for the killing of the intracellular parasites. We have recently shown that, in addition to M Phi, epidermal Langerhans cells (LC) can phagocytose Leishmania major, but they do not allow parasite replication. Therefore, we analyzed whether LC and M Phi display the same leishmanicidal effector mechanism. Unlike M Phi, stimulation of unselected epidermal cells with interferon-gamma/lipopolysaccharide did not lead to the release of nitric oxide (NO), and inhibition of NO production had no effect on the rate of infection of LC. iNOS mRNA was clearly detectable in M Phi as well as unselected epidermal cells (the majority of which consists of keratinocytes) after stimulation with different cytokines. In contrast, pure LC obtained by single-cell picking from cytokine-activated or L. major- infected epidermal cells did not express iNOS mRNA. Addition of the WO donor S-nitroso-N-acetylpenicillamine to already-infected LC did not alter their rate of infection, indicating that LC do not utilize exogenous NO for the control of intracellular Leishmania. These results suggest that in the L. major-infected skin. activated M Phi and keratinocytes, bur nor LC have the ability to express iNOS activity. Therefore, an as yet unidentified. NO-independent mechanism appears to be responsible for the control of parasite replication in LC.
引用
收藏
页码:792 / 796
页数:5
相关论文
共 50 条
  • [31] Inducible nitric oxide synthase in uterine smooth muscle
    Nakaya, Y
    Yamamoto, S
    Hamada, Y
    Kamada, M
    Aono, T
    Niwa, M
    LIFE SCIENCES, 1996, 58 (13) : PL249 - PL255
  • [32] Inducible nitric oxide synthase in the liver: Regulation and function
    Taylor, BS
    Alarcon, LH
    Billiar, TR
    BIOCHEMISTRY-MOSCOW, 1998, 63 (07) : 766 - 781
  • [33] Hypergravity upregulates renal inducible nitric oxide synthase expression and nitric oxide production
    Yoon, Gun
    Oh, Choong Sik
    Kim, Hyun-Soo
    ONCOTARGET, 2016, 7 (21): : 30147 - 30154
  • [34] Induction of inducible nitric oxide synthase expression by neopterin in vascular smooth muscle cells
    Schobersberger, W
    Hoffmann, G
    Grote, J
    Wachter, H
    Fuchs, D
    FEBS LETTERS, 1995, 377 (03) : 461 - 464
  • [35] Nicotinamide inhibits inducible nitric oxide synthase mRNA in primary rat glial cells
    Fujimura, M
    Tominaga, T
    Yoshimoto, T
    NEUROSCIENCE LETTERS, 1997, 228 (02) : 107 - 110
  • [36] In vitro formation of S-nitrosohemoglobin in red cells by inducible nitric oxide synthase
    Mamone, G
    Sannolo, N
    Malorni, A
    Ferranti, P
    FEBS LETTERS, 1999, 462 (03) : 241 - 245
  • [37] Novel peptides enhance the production of nitric oxide and inducible nitric oxide synthase (iNOS) gene expression in murine macrophage
    Acharya, A
    Tripathi, V
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2003, 16 (03) : 241 - 246
  • [38] Insulin inhibits inducible nitric oxide synthase in skeletal muscle cells
    Bédard, S
    Marcotte, B
    Marette, A
    DIABETOLOGIA, 1998, 41 (12) : 1523 - 1527
  • [39] L-Arginine and nitric oxide synthesis in the cells with inducible NO synthase
    Kuropteva, Z., V
    Baider, L. M.
    Nagler, L. G.
    Bogatyrenko, T. N.
    Belaia, O. L.
    RUSSIAN CHEMICAL BULLETIN, 2019, 68 (01) : 174 - 180
  • [40] Insulin inhibits inducible nitric oxide synthase in skeletal muscle cells
    S. Bédard
    B. Marcotte
    A. Marette
    Diabetologia, 1998, 41 : 1523 - 1527